15 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32116227 | [Electroanalytical and electrocatalytical characteristics of cytochrome P450 3A4 using electrodes modified with nanocomposite carbon nanomaterials]. | 2020 Jan | 1 |
2 | 29593874 | Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction. | 2018 Mar | 2 |
3 | 30072148 | Concomitant use of statins and macrolide antibiotics and risk of serious renal events: A nationwide cohort study. | 2018 Oct 15 | 1 |
4 | 28069789 | Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin. | 2017 Jan 9 | 4 |
5 | 28990114 | Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions. | 2017 Oct 9 | 1 |
6 | 22237927 | Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. | 2012 May | 1 |
7 | 18220568 | Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5. | 2008 Jan | 1 |
8 | 12949438 | Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology. | 2003 | 1 |
9 | 12235267 | Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. | 2002 Oct | 1 |
10 | 11197581 | Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin. | 2001 Jan | 1 |
11 | 11095572 | Effects of macrolide antibiotics on CYP3A expression in human and rat hepatocytes: interspecies differences in response to troleandomycin. | 2000 Dec | 1 |
12 | 10088712 | In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle. | 1999 Feb | 2 |
13 | 9084959 | Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. | 1997 Mar | 1 |
14 | 7576262 | Macrolide antibacterials. Drug interactions of clinical significance. | 1995 Aug | 1 |
15 | 2269307 | Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme. | 1990 Dec 27 | 2 |